Ixazomib with lenalidomide and dexamethasone for patients with relapsed multiple myeloma: impact of 17p deletion and sensitivity to proteasome inhibitors from a real world data-set.

Autor: Ziff, Monica1 (AUTHOR), Lawson, Gabrielle1 (AUTHOR), De-Silva, Dunnya1 (AUTHOR), Cheesman, Simon1 (AUTHOR), Kyriakou, Charalampia1 (AUTHOR), Mahmood, Shameem1 (AUTHOR), Papanikolaou, Xenofon1 (AUTHOR), Rabin, Neil1 (AUTHOR), Sachchithananthan, Sajitha1 (AUTHOR), Sive, Jonathan1 (AUTHOR), Wechalekar, Ashutosh1 (AUTHOR), Yong, Kwee1 (AUTHOR), Popat, Rakesh1 (AUTHOR)
Zdroj: Leukemia & Lymphoma. May2021, Vol. 62 Issue 5, p1243-1246. 4p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje